BioAmber Inc.
BIOA.WS
BIOA.WS was delisted on the 3rd of May, 2017.
11 hedge funds and large institutions have $8.36M invested in BioAmber Inc. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
38% more funds holding
Funds holding: 8 → 11 (+3)
7% less capital invested
Capital invested by funds: $8.95M → $8.36M (-$593K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$282K |
| 2 |
LCS
Levin Capital Strategies
New York
|
+$199K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.88K |
| 4 |
Barclays
London,
United Kingdom
|
+$117 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$68.8K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$3.01K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WRF
1
Waddell & Reed Financial
Overland Park,
Kansas
| $5.16M | – | – | – |
|
|
PRCM
2
Pine River Capital Management
Minnetonka,
Minnesota
| $892K | -$68.8K | -36,564 | -7% |
|
|
ACPU
3
Arrowgrass Capital Partners (US)
Dover,
Delaware
| $669K | – | – | – |
|
|
LCS
4
Levin Capital Strategies
New York
| $536K | +$199K | +105,650 | +54% |
|
|
MCM
5
Moore Capital Management
New York
| $454K | – | – | – |
|
|
SFM
6
Soros Fund Management
New York
| $345K | – | – | – |
|
|
MIM
7
Monashee Investment Management
Boston,
Massachusetts
| $267K | +$282K | +150,000 | New |
|
|
PWAM
8
Park West Asset Management
San Francisco,
California
| $27K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $2K | +$1.88K | +1,000 | New |
|
|
10
Bank of America
Charlotte,
North Carolina
| $1K | -$3.01K | -1,602 | -74% |
|
|
11
Barclays
London,
United Kingdom
| – | +$117 | +62 | New |
|
BIOA.WS Hedge Fund Activity: Q3 2015 in Review
11 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA.WS) for Q3 2015, worth a combined $8.36M — down 6.6% from $8.95M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BIOA.WS positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Monashee Investment Management, opening a new position worth an estimated $282K. The largest seller was Pine River Capital Management, cutting an estimated $68.8K.
- 11 institutional investors held BioAmber Inc. (BIOA.WS) as of Q3 2015, up from 8 in Q2 2015.
- Funds reported $8.36M of BioAmber Inc. stock for Q3 2015, down 6.6% quarter-over-quarter.
- 3 funds opened new BioAmber Inc. positions in Q3 2015 and 0 closed out, a net change of +3 holders.
- The largest BioAmber Inc. buyer in Q3 2015 was Monashee Investment Management, an estimated $282K added.
- The largest BioAmber Inc. seller in Q3 2015 was Pine River Capital Management, an estimated $68.8K sold.
Based on aggregated 13F filings for Q3 2015.